CVS Health (NYSE:CVS) Given New $73.00 Price Target at Barclays

CVS Health (NYSE:CVS) had its target price increased by investment analysts at Barclays from $71.00 to $73.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the pharmacy operator’s stock. Barclays‘s price target would indicate a potential upside of 15.45% from the company’s previous close.

Other equities research analysts also recently issued research reports about the company. Leerink Partners upgraded CVS Health from a “market perform” rating to an “outperform” rating and boosted their price objective for the company from $55.00 to $75.00 in a report on Thursday. Evercore ISI boosted their price target on shares of CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research note on Monday, January 27th. Truist Financial lowered their price objective on shares of CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a research note on Tuesday, December 3rd. Finally, TD Cowen raised their price target on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, November 25th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and seventeen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $69.00.

CVS Health Trading Up 15.0 %

NYSE CVS opened at $63.23 on Thursday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The stock has a market capitalization of $79.57 billion, a P/E ratio of 16.05, a PEG ratio of 0.60 and a beta of 0.61. The firm’s 50-day moving average is $50.71 and its two-hundred day moving average is $55.94. CVS Health has a 12 month low of $43.56 and a 12 month high of $80.75.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. On average, sell-side analysts anticipate that CVS Health will post 5.14 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of CVS. Russell Investments Group Ltd. increased its position in shares of CVS Health by 62.3% during the fourth quarter. Russell Investments Group Ltd. now owns 3,173,780 shares of the pharmacy operator’s stock worth $142,464,000 after purchasing an additional 1,217,730 shares in the last quarter. Rahlfs Capital LLC purchased a new position in CVS Health during the 4th quarter worth approximately $266,000. Envestnet Asset Management Inc. increased its position in CVS Health by 1.0% during the fourth quarter. Envestnet Asset Management Inc. now owns 1,529,714 shares of the pharmacy operator’s stock worth $68,669,000 after buying an additional 15,561 shares during the period. Aviva PLC lifted its stake in CVS Health by 154.9% in the fourth quarter. Aviva PLC now owns 681,209 shares of the pharmacy operator’s stock valued at $30,579,000 after buying an additional 414,008 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of CVS Health in the fourth quarter valued at approximately $1,111,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.